Under construction – not a live service
Sign in
Taking people in DenmarkNo phase

Tests two surgery methods to prevent Crohn's disease from returning

Compares two bowel surgeries in adults with Crohn's disease in the lower intestine.

Plain-language title generated from the registry record
Registry title: Extended Mesenteric Resection in Ileocecal Crohn's Disease.

Key facts

Where
Odense, DenmarkSee the site

Where in Denmark

  • Odense University HospitalOdense, DenmarkTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Odense University Hospital
Trial code
NCT06324838
Record updated
15 January 2026
Original description
The EXCEED project aims to study the role of the mesentery in disease recurrence in Crohn's disease (CD), as evidence suggests that including the mesentery when doing ileocecal resections can significantly reduce recurrence rates. The EXCEED study is a blinded randomised clinical trial with 204 participants having ileocecal Crohn's disease requiring resection. Participants will undergo either "standard" mesocolic sparing resection or extended mesocolic resection to assess its impact on reducing recurrence at the anastomotic site. The primary endpoint is endoscopic recurrence 12 months postoperatively.Read full original descriptionShow less

Extended Mesenteric Resection in Ileocecal Crohn's Disease to Prevent Recurrent Disease - A Randomized Controlled Trial.

The EXCEED project aims to study the role of the mesentery in disease recurrence in Crohn's disease (CD), as evidence suggests that including the mesentery when doing ileocecal resections can significantly reduce recurrence rates. The EXCEED study is a blinded randomised clinical trial with 204 participants having ileocecal Crohn's disease requiring resection. Participants will undergo either "standard" mesocolic sparing resection or extended mesocolic resection to assess its impact on reducing recurrence at the anastomotic site. The primary endpoint is endoscopic recurrence 12 months postoperatively.

Additionally, the study aims to evaluate the efficacy of different surveillance modalities in detecting anastomotic site recurrence. These examinations will be conducted pre- and postoperatively for a cohort of 20 participants.

Through this study, we seek to understand the mesentery's role in Crohn's disease recurrence and identify effective non-invasive methods for postoperative monitoring.

Inclusion: Patients above the age of 18 scheduled for ileocecal resection due to Crohn's disease; Relevant endoscopy and imaging within the last 6 months; Diagnosis of "simple" ileocecal Crohn's disease (limited to ileocecal disease with a maximum of 40 cm of affected ileum).

Exclusion: Previous ileocecal resection; Inability to understand Danish or another Nordic language; Inability to comprehend the purpose and design of the project; Pregnancy or lactation.

ClinicalTrials.gov NCT06324838